Lena Marions

ORCID: 0000-0002-5930-4485 · 15 papers in corpus · active 1999-2023

Study types

  • article 11
  • dataset 2
  • other 2

Condition tags

  • endometriosis 12
  • dysmenorrhea 6
  • chronic_pelvic_pain 5
  • infertility 1
  • dyspareunia 1
dataset 2023
·doi:10.48723/875f-ma81

Purpose: Considering the pharmacological treatment options for endometriosis-associated pain are confined to hormonal therapy and analgesics, we studied the analgesic effect of 20 mg melatonin as an adjuvant therapy in women with endometrio…

dataset 2023
·doi:10.5878/qttp-wh10

Purpose: Considering the pharmacological treatment options for endometriosis-associated pain are confined to hormonal therapy and analgesics, we studied the analgesic effect of 20 mg melatonin as an adjuvant therapy in women with endometrio…

article 2023
PloS one ·doi:10.1371/journal.pone.0286182

Considering the pharmacological treatment options for endometriosis-associated pain are confined to hormonal therapy and analgesics, we studied the analgesic effect of 20 mg melatonin as an adjuvant therapy in women with endometriosis-assoc…

article 2021
European journal of clinical pharmacology ·doi:10.1007/s00228-021-03234-6

PURPOSE: Dysmenorrhea is a common, recurring, painful condition with a global prevalence of 71%. The treatment regime for dysmenorrhea includes hormonal therapies and NSAID, both of which are associated with side effects. A dose of 10 mg me…

article 2021
·doi:10.1177/22840265211035993

Introduction: Women with endometriosis require individualized, long-term treatment. Analyzing prescription choices, medication switches, discontinuations, and breaks can describe real-world treatment patterns and optimize pathways for women…

article 2021
Scientific reports ·doi:10.1038/s41598-021-99681-3

Endometriosis is a chronic disease that requires a suitable, lifelong treatment. To our knowledge, the Visanne Post-approval Observational Study (VIPOS) is to date the largest real-world, non-interventional study investigating hormonal mana…

article 2020
Advances in therapy ·doi:10.1007/s12325-020-01331-z

INTRODUCTION: Endometriosis is a common gynecologic disease associated with a significant burden on women's health and healthcare systems. Currently approved hormonal treatments for endometriosis can be effective in controlling symptoms, bu…

other 2019
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.13480

INTRODUCTION: The objective of this study was to estimate the prevalence of dysmenorrhea among adolescents and its effect on daily life. MATERIAL AND METHODS: A web-based questionnaire with questions regarding menstrual symptoms was distri…

article 2018
·doi:10.1016/j.fertnstert.2018.07.1095
other 2018
Lakartidningen
article 2016
Journal of women's health (2002) ·doi:10.1089/jwh.2016.5795

OBJECTIVES: Despite the high prevalence of endometriosis among women of reproductive age, risk factors or markers for developing the condition remain largely unknown. Many of the published studies are based on small selected samples. We the…

article 2016
Fertility and sterility ·doi:10.1016/j.fertnstert.2016.09.038
article 2015
Fertility and sterility ·doi:10.1016/j.fertnstert.2015.06.035
article 2013
·doi:10.1111/aogs.12292

OBJECTIVE: To investigate the prevalence of women subjectively experiencing heavy menstrual bleeding in the general population and their health-related quality of life (HRQoL) compared with women experiencing normal menstrual blood loss. DE…

article 1999
·doi:10.1093/molehr/5.10.961

Prostaglandins (PG) are known to be involved in the process of human implantation. In several animal species treatment with prostaglandin synthesis inhibitors will prevent implantation. Cyclo-oxygenase (COX) is the rate-limiting enzyme in t…